What does CUSIP 30049G104 represent in this 13F holders report?

CUSIP 30049G104 is the security identifier for EVOK - EVOKE PHARMA INC - COM used to aggregate holder disclosures.

How many institutions held EVOK - EVOKE PHARMA INC - COM in Q4 2013?

7 institutional investors reported EVOK - EVOKE PHARMA INC - COM for Q4 2013. Use the holders table for investor-level position and value details.

EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class: Equity / COM
Total 13F shares: 155,832
Share change: 0
Total reported value: $1,161,000
Price per share: $7.45
Number of holders: 7

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2014

Recent filing periods for CUSIP 30049G104:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q4 2013

As of 31 Dec 2013, EVOKE PHARMA INC - COM (EVOK) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,832 shares. The largest 7 holders included LMR Master Fund Ltd, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, TFS CAPITAL LLC, A.R.T. Advisors, LLC, and UBS AG. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2013 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.